NP0332570 | 1S,5S,7R,8R,3-exo,7-endo-(+)-9-deoxygoniopypyrone | | | C13H14O4
234.2510 Da 234.08921 Da | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | [1H , 1H ]-NOESY NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 501 MHz, CDCl3, experimental) |
|
NP0332571 | Triacyl myo-inositol I3:22(i4,i4,n14) | | | C28H50O9
530.6990 Da 530.34548 Da | 1H NMR Spectrum (1D, 800 MHz, CD3CN, simulated) | 13C NMR Spectrum (1D, 201 MHz, CD3CN, simulated) | 1H NMR Spectrum (1D, 801 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 202 MHz, CD3CN, experimental) |
|
NP0332572 | Triacyl myo-inositol I3:22(i4,i4,(3R)-OH-n14) | | | C28H50O10
546.6980 Da 546.34040 Da | |
NP0332573 | Triacyl myo-inositol I3:22(i4,i4,3-OH-i14) | | | C28H50O10
546.6980 Da 546.34040 Da | |
NP0332574 | Triacyl myo-inositol I3:22(i4,i4,i14) | | | C28H50O9
530.6990 Da 530.34548 Da | 1H NMR Spectrum (1D, 600 MHz, CD3CN, simulated) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, simulated) | 1H NMR Spectrum (1D, 601 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) |
|
NP0332575 | 4-O-β-arabinosyl-myo-inositol | | | C11H20O10
312.2710 Da 312.10565 Da | |
NP0332576 | Taveuniamide N | | | C17H23Cl4NO
399.1800 Da 397.05338 Da | |
NP0332577 | Taveuniamide M | | | C17H25Cl4NO
401.1900 Da 399.06903 Da | |
NP0332578 | Taveuniamide F | | | C17H26Cl3NO
366.7500 Da 365.10800 Da | |
NP0332579 | Taveuniamide L | | | C17H24Cl3NO
364.7400 Da 363.09235 Da | |
NP0332580 | Neocyathin F | | | C40H56O10
696.8780 Da 696.38735 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 501 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) |
|
NP0332581 | Neocyathin E | | | C20H30O4
334.4560 Da 334.21441 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 501 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) |
|
NP0332582 | Neocyathin C | | | C20H30O5
350.4550 Da 350.20932 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, simulated) | 1H NMR Spectrum (1D, 501 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) |
|
NP0332583 | Akunolide B acyclic derivative | | | C36H68O11
676.9290 Da 676.47616 Da | |
NP0332584 | Akunolide B acetonide derivative | | | C39H72O11
716.9940 Da 716.50746 Da | [1H , 1H ]-NOESY NMR Spectrum (1D, 392 MHz, C6D6, experimental) | 1H NMR Spectrum (1D, 396 MHz, C6D6, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 396 MHz, C6D6, experimental) | [1H , 13C ]-HMQC NMR Spectrum (1D, 396 MHz, C6D6, experimental) |
|
NP0332585 | Fimbricalyxoid E | | | C18H20O5
316.3530 Da 316.13107 Da | |
NP0332586 | Fimbricalyxoid F | | | C16H18O4
274.3160 Da 274.12051 Da | |
NP0332587 | Fimbricalyxone | | | C17H16O4
284.3110 Da 284.10486 Da | |
NP0332588 | Fimbricalxyxanhydride C | | | C17H14O6
314.2930 Da 314.07904 Da | |
NP0332589 | 1-hydroarmillaricin | | | C24H29ClO5
432.9400 Da 432.17035 Da | 13C NMR Spectrum (1D, 176 MHz, C3D6O, simulated) | 1H NMR Spectrum (1D, 700 MHz, C3D6O, simulated) | [1H , 1H ]-COSY NMR Spectrum (1D, 701 MHz, C3D6O, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 701 MHz, C3D6O, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 701 MHz, C3D6O, experimental) | 13C NMR Spectrum (1D, 177 MHz, C3D6O, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 701 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 701 MHz, C3D6O, experimental) |
|
NP0332590 | 5’-O-desmethylarmillaribin | | | C23H26O5
382.4560 Da 382.17802 Da | 13C NMR Spectrum (1D, 126 MHz, C3D6O, simulated) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 501 MHz, C3D6O, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 501 MHz, C3D6O, experimental) | [1H , 13C ]-HSQC NMR Spectrum (1D, 501 MHz, C3D6O, experimental) | [1H , 1H ]-ROESY NMR Spectrum (1D, 501 MHz, C3D6O, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 501 MHz, C2D6OS, experimental) |
|
NP0332591 | Kavaratamide A | | | C32H55N3O8
609.8050 Da 609.39892 Da | [1H , 1H ]-COSY NMR Spectrum (1D, 501 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H , 13C ]-HMBC NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H , 1H ]-NOESY NMR Spectrum (1D, 501 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 501 MHz, CDCL3, experimental) |
|
NP0332592 | Compound 12a | | | C33H38O10
594.6570 Da 594.24650 Da | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 501 MHz, CDCl3, experimental) |
|
NP0332593 | Compound 8 | | | C30H34O8
522.5940 Da 522.22537 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 601 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) |
|
NP0332594 | Compound 12b | | | C33H38O10
594.6570 Da 594.24650 Da | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | 1H NMR Spectrum (1D, 501 MHz, CDCl3, experimental) | [1H , 1H ]-COSY NMR Spectrum (1D, 501 MHz, CDCl3, experimental) |
|